TechSeeker Profile

Roche Holding AG
Profile last edited on: 5/19/2016

NO Business Identifier is currently available for this company.
TS Type
Major Corp
Year Founded
Last Involved Year

Key People / Management

  Franz B Humer -- CEO

  Jack Phillips -- Chief Executive Officer and President

  Teresa Anglin --

  Wendy Benson --

  Lauren N Cabasino -- Accountant

  Nancy M Cohen -- Sr. Vice President, Legal

  Donna J Donohue --

  Terry Fetterhoff --

  Terry Fetterhoff -- Sr Director Technology Ma

  Terry Fetterhoff -- Director, Technology Mana

  Laurie Gould --

  Michael V Hansen -- Director, Business Develo

  Song Hu --

  Katherine Kiehn -- Senior Licensing Manager

  William E Lief -- Director, PC, NPP

  Lucy H Lu -- Director, Technology Mana

  George Martin --

  George Martin --

  Mark Noguchi -- V.P., Strategic Marketing

  Pamela Ostroff -- Director of Licensing and

  Valeria Povolotsky --

  Klaus Raddatz -- Germany

  James A Ramaker -- Licensing Finance Manager

  Neal R Roach -- Head of Global Licensing

  Ann M Stiewig -- Sr.Marketing Research and

  Joe Tasto --

  Jeffrey A Vivian --

  Dirk Voelkel -- Director, Technology Mana

  Kenneth J Waite --

  Monte Wetzel --

  Monte Wetzel --

  Phyllis E Whiteley -- Vice President, Global Al

  Joanne Yee --

Location Information

Konzern-Hauptsitz Grenzacherstrasse 124
Basel, SW 4070
   (416) 168-81111

Public Profile

Based in Basel, Switzerland, Roche Holding AG is the owner of F. Hoffmann-La Roche Ltd., a provider of in-vitro diagnostics and drugs for cancer and transplantation. Traded on the SwissExchange, Active in over 100 countries and the largest biotech firm inthe work. Roche is working on medicines for oncology, virology, inflammation, metabolism, CNS, clinical chemistry, immunology, urinalysis, blood screening, genetics, infectious diseases, and microbiology. F. Hoffmann-La Roche Ltd. serves hospitals, research labs, private medical labs, practicing physicians, and patients. Specific products include cancer treatments, such as Avastin, Herceptin, and MabThera that are also effective in the treatment of rheumatoid arthritis, anemia, and osteoporosis. F. Hoffmann-La Roche Ltd., also conducts research and development as well as production related to molecular diagnostic reagents, test systems, and test kits. In addition, the firm provides automated instruments, software, consumables, and IT solutions used in in-vitro diagnostics and research.

Extent of SBIR involvement

User Avatar

Synopsis: Techseeker Business Condition

Publicly Traded
Stock Info
Received SBIR $$